A citation-based method for searching scientific literature

Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, F Zattoni, Nicolas Mottet. Eur Urol 2014
Times Cited: 1402







List of co-cited articles
346 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, Erik Briers, Marcus G Cumberbatch, Maria De Santis, Nicola Fossati, Tobias Gross, Ann M Henry, Steven Joniau,[...]. Eur Urol 2017
20

PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.
Jeffrey C Weinreb, Jelle O Barentsz, Peter L Choyke, Francois Cornud, Masoom A Haider, Katarzyna J Macura, Daniel Margolis, Mitchell D Schnall, Faina Shtern, Clare M Tempany,[...]. Eur Urol 2016
12

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.
A V D'Amico, R Whittington, S B Malkowicz, D Schultz, K Blank, G A Broderick, J E Tomaszewski, A A Renshaw, I Kaplan, C J Beard,[...]. JAMA 1998
12


MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Veeru Kasivisvanathan, Antti S Rannikko, Marcelo Borghi, Valeria Panebianco, Lance A Mynderse, Markku H Vaarala, Alberto Briganti, Lars Budäus, Giles Hellawell, Richard G Hindley,[...]. N Engl J Med 2018
9

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
9

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Hashim U Ahmed, Ahmed El-Shater Bosaily, Louise C Brown, Rhian Gabe, Richard Kaplan, Mahesh K Parmar, Yolanda Collaco-Moraes, Katie Ward, Richard G Hindley, Alex Freeman,[...]. Lancet 2017
8

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
7

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
Marloes van der Leest, Erik Cornel, Bas Israël, Rianne Hendriks, Anwar R Padhani, Martijn Hoogenboom, Patrik Zamecnik, Dirk Bakker, Anglita Yanti Setiasti, Jeroen Veltman,[...]. Eur Urol 2019
331
7

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
Philip Cornford, Joaquim Bellmunt, Michel Bolla, Erik Briers, Maria De Santis, Tobias Gross, Ann M Henry, Steven Joniau, Thomas B Lam, Malcolm D Mason,[...]. Eur Urol 2017
937
6

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
639
6


10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
Freddie C Hamdy, Jenny L Donovan, J Athene Lane, Malcolm Mason, Chris Metcalfe, Peter Holding, Michael Davis, Tim J Peters, Emma L Turner, Richard M Martin,[...]. N Engl J Med 2016
6

ESUR prostate MR guidelines 2012.
Jelle O Barentsz, Jonathan Richenberg, Richard Clements, Peter Choyke, Sadhna Verma, Geert Villeirs, Olivier Rouviere, Vibeke Logager, Jurgen J Fütterer. Eur Radiol 2012
6

Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy.
Matthias Eiber, Tobias Maurer, Michael Souvatzoglou, Ambros J Beer, Alexander Ruffani, Bernhard Haller, Frank-Philipp Graner, Hubert Kübler, Uwe Haberkorn, Michael Eisenhut,[...]. J Nucl Med 2015
723
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Alberto Briganti, Alessandro Larcher, Firas Abdollah, Umberto Capitanio, Andrea Gallina, Nazareno Suardi, Marco Bianchi, Maxine Sun, Massimo Freschi, Andrea Salonia,[...]. Eur Urol 2012
438
5

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Axel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, Filiberto Zattoni,[...]. Eur Urol 2014
960
5

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.
Stephen A Boorjian, R Jeffrey Karnes, Rosalia Viterbo, Laureano J Rangel, Eric J Bergstralh, Eric M Horwitz, Michael L Blute, Mark K Buyyounouski. Cancer 2011
195
5

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.
Baris Turkbey, Andrew B Rosenkrantz, Masoom A Haider, Anwar R Padhani, Geert Villeirs, Katarzyna J Macura, Clare M Tempany, Peter L Choyke, Francois Cornud, Daniel J Margolis,[...]. Eur Urol 2019
629
5

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.
Marlon Perera, Nathan Papa, Daniel Christidis, David Wetherell, Michael S Hofman, Declan G Murphy, Damien Bolton, Nathan Lawrentschuk. Eur Urol 2016
637
5

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
Mack Roach, Gerald Hanks, Howard Thames, Paul Schellhammer, William U Shipley, Gerald H Sokol, Howard Sandler. Int J Radiat Oncol Biol Phys 2006
5

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
J L Donovan, F C Hamdy, J A Lane, M Mason, C Metcalfe, E Walsh, J M Blazeby, T J Peters, P Holding, S Bonnington,[...]. N Engl J Med 2016
684
5

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.
Ali Afshar-Oromieh, Eleni Avtzi, Frederik L Giesel, Tim Holland-Letz, Heinz G Linhart, Matthias Eder, Michael Eisenhut, Silvan Boxler, Boris A Hadaschik, Clemens Kratochwil,[...]. Eur J Nucl Med Mol Imaging 2015
683
5

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.
A M Hövels, R A M Heesakkers, E M Adang, G J Jager, S Strum, Y L Hoogeveen, J L Severens, J O Barentsz. Clin Radiol 2008
571
4

Pelvic lymph node dissection in prostate cancer.
Alberto Briganti, Michael L Blute, James H Eastham, Markus Graefen, Axel Heidenreich, Jeffrey R Karnes, Francesco Montorsi, Urs E Studer. Eur Urol 2009
368
4

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
440
4

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Jonathan I Epstein, William C Allsbrook, Mahul B Amin, Lars L Egevad. Am J Surg Pathol 2005
4

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
833
4

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad M Martin, Mark Frydenberg, Ramdave Shakher,[...]. Lancet 2020
543
4

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study.
Geoffrey D Coughlin, John W Yaxley, Suzanne K Chambers, Stefano Occhipinti, Hema Samaratunga, Leah Zajdlewicz, Patrick Teloken, Nigel Dunglison, Scott Williams, Martin F Lavin,[...]. Lancet Oncol 2018
173
4

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study.
John W Yaxley, Geoffrey D Coughlin, Suzanne K Chambers, Stefano Occhipinti, Hema Samaratunga, Leah Zajdlewicz, Nigel Dunglison, Rob Carter, Scott Williams, Diane J Payton,[...]. Lancet 2016
368
4

Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
Lisa Moris, Marcus G Cumberbatch, Thomas Van den Broeck, Giorgio Gandaglia, Nicola Fossati, Brian Kelly, Raj Pal, Erik Briers, Philip Cornford, Maria De Santis,[...]. Eur Urol 2020
65
6

Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
Claire L Vale, David Fisher, Andrew Kneebone, Christopher Parker, Maria Pearse, Pierre Richaud, Paul Sargos, Matthew R Sydes, Christopher Brawley, Meryem Brihoum,[...]. Lancet 2020
114
4

Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia.
Clara Pérez-Rambla, Leonor Puchades-Carrasco, María García-Flores, José Rubio-Briones, José Antonio López-Guerrero, Antonio Pineda-Lucena. Metabolomics 2017
39
10

Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
Guro F Giskeødegård, Helena Bertilsson, Kirsten M Selnæs, Alan J Wright, Tone F Bathen, Trond Viset, Jostein Halgunset, Anders Angelsen, Ingrid S Gribbestad, May-Britt Tessem. PLoS One 2013
118
4

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
M Minhaj Siddiqui, Soroush Rais-Bahrami, Baris Turkbey, Arvin K George, Jason Rothwax, Nabeel Shakir, Chinonyerem Okoro, Dima Raskolnikov, Howard L Parnes, W Marston Linehan,[...]. JAMA 2015
4

Natural history of progression after PSA elevation following radical prostatectomy.
C R Pound, A W Partin, M A Eisenberger, D W Chan, J D Pearson, P C Walsh. JAMA 1999
4

Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.
Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L Giesel, Clemens Kratochwil, Walter Mier, Sabine Haufe, Nils Debus, Matthias Eder, Michael Eisenhut, Martin Schäfer,[...]. Eur J Nucl Med Mol Imaging 2017
326
4

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
Marlon Perera, Nathan Papa, Matthew Roberts, Michael Williams, Cristian Udovicich, Ian Vela, Daniel Christidis, Damien Bolton, Michael S Hofman, Nathan Lawrentschuk,[...]. Eur Urol 2020
359
4

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
Axel Heidenreich, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Malcolm Mason, Vsevolod Matveev, Nicolas Mottet, Hans-Peter Schmid, Theo van der Kwast, Thomas Wiegel,[...]. Eur Urol 2011
4

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
4

Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis.
Jianjian Xiang, Huaqing Yan, Jiangfeng Li, Xiao Wang, Hong Chen, Xiangyi Zheng. World J Surg Oncol 2019
81
4

Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Joshua J Morigi, Phillip D Stricker, Pim J van Leeuwen, Reuben Tang, Bao Ho, Quoc Nguyen, George Hruby, Gerald Fogarty, Raj Jagavkar, Andrew Kneebone,[...]. J Nucl Med 2015
390
4

68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.
Wolfgang P Fendler, Matthias Eiber, Mohsen Beheshti, Jamshed Bomanji, Francesco Ceci, Steven Cho, Frederik Giesel, Uwe Haberkorn, Thomas A Hope, Klaus Kopka,[...]. Eur J Nucl Med Mol Imaging 2017
368
4

Epidemiology of Prostate Cancer.
Prashanth Rawla. World J Oncol 2019
645
4

Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Thomas Wiegel, Dirk Bottke, Ursula Steiner, Alessandra Siegmann, Reinhard Golz, Stephan Störkel, Norman Willich, Axel Semjonow, Rainer Souchon, Michael Stöckle,[...]. J Clin Oncol 2009
638
4

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.
L Bubendorf, A Schöpfer, U Wagner, G Sauter, H Moch, N Willi, T C Gasser, M J Mihatsch. Hum Pathol 2000
3

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.
Tobias Maurer, Jürgen E Gschwend, Isabel Rauscher, Michael Souvatzoglou, Bernhard Haller, Gregor Weirich, Hans-Jürgen Wester, Matthias Heck, Hubert Kübler, Ambros J Beer,[...]. J Urol 2016
477
3

Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
Matti Annala, Werner J Struss, Evan W Warner, Kevin Beja, Gillian Vandekerkhove, Amanda Wong, Daniel Khalaf, Irma-Liisa Seppälä, Alan So, Gregory Lo,[...]. Eur Urol 2017
135
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.